|1.||Martin, Ola J: 1 article (04/2014)|
|2.||Muoio, Deborah M: 1 article (04/2014)|
|3.||Noland, Robert C: 1 article (04/2014)|
|4.||DeBalsi, Karen L: 1 article (04/2014)|
|5.||An, Jie: 1 article (04/2014)|
|6.||Newgard, Christopher B: 1 article (04/2014)|
|7.||Ilkayeva, Olga R: 1 article (04/2014)|
|8.||Koves, Timothy R: 1 article (04/2014)|
|9.||Seiler, Sarah E: 1 article (04/2014)|
|10.||Slentz, Dorothy H: 1 article (04/2014)|
09/18/2012 - "Consistent with these targets as contributors to the metabolic actions of miR-378 and miR-378*, previous studies have implicated carnitine O-acetyltransferase and MED13 in metabolic syndrome and obesity. "
04/01/2014 - "Obesity and lipid stress inhibit carnitine acetyltransferase activity."
|2.||Peripheral Vascular Diseases (Peripheral Vascular Disease)
|3.||Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/01/2003 - "Considering the risk of acquiring a myelodysplastic syndrome (MDS) with age, the aim of this study was to quantify mRNA synthesis of the carnitine palmitoyltransferases (CPT1 and CPT2), carnitine acetyltransferase (CRAT), human specific microsomal CPT, and OCTN2 (organic cation transporter) in mononuclear cells of healthy humans of different age groups and MDS patients. "
|4.||Body Weight (Weight, Body)
12/01/1987 - "Five daily oral doses of di(2-ethylhexyl) phthalate (DEHP) (2 g/kg) given to rats on Days 2-6, 6-10, or 14-18 of lactation caused significant decreases in body weight and increases in hepatic peroxisomal enzymes palmitoyl CoA oxidase and carnitine acetyltransferase in the dams and their suckling pups. "
10/01/1981 - "1) Vitamin B2-butyrate (100 mg/kg) and nicomol (lg/Kg) increased carnitine acetyltransferase and D-amino acid oxidase activities, respectively, while these drugs had no influence on body weight, liver weight, serum and liver triglyceride, and serum and liver cholesterol levels. "
03/17/1992 - "After DHEA treatment (300 mg/kg body weight, per os, 14 days), the activities of peroxisomal beta-oxidation, catalase, carnitine acetyltransferase, carnitine palmitoyltransferase, lauric acid omega-hydroxylation, 1-acylglycerophosphocholine acyltransferase, malic enzyme and cytosolic palmitoyl-CoA hydrolase were increased in rats and in mice although to a smaller extent in the latter. "
|5.||Alzheimer Disease (Alzheimer's Disease)
10/01/1992 - "We found a 25 to 40% decrease in carnitine acetyltransferase activity in patients with Alzheimer's disease, which attained statistical significance in most brain regions and in cerebral microvessels. "
10/01/1992 - "Carnitine acetyltransferase activity in the human brain and its microvessels is decreased in Alzheimer's disease."
08/01/2012 - "Chromatographic separation of reaction products from the choline acetyltransferase and carnitine acetyltransferase assay: differential ChAT and CrAT activity in brain extracts from Alzheimer's disease versus controls."
06/01/1998 - "We evaluated the activities of carnitine palmitoyltransferase (CPT), carnitine octanoyltransferase (COT), and carnitine acetyltransferase (CAT) in the frontal cortex, temporal cortex, parietal cortex, hippocampus, and cerebellum of Alzheimer disease (AD) patients and normal human brains. "
|2.||Messenger RNA (mRNA)
|4.||Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)
|9.||palmitoyl CoA oxidase
|10.||Riboflavin (Vitamin B2)